SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yajing Zhang, Wenying Zhang, Hanren Dai, Yao Wang, Fengxia Shi, Chunmeng Wang, Yelei Guo, Yang Liu, Meixia Chen, Kaichao Feng, Yan Zhang, Chuanjie Liu, Qingming Yang, Suxia Li, Weidong Han, An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells, Science China Life Sciences, 2016, 59, 4, 379

    CrossRef

  2. 2
    Jing-Zhang Wang, Yu-Hua Zhang, Xin-Hua Guo, Hong-Yan Zhang, Yuan Zhang, The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy, International Immunopharmacology, 2016, 36, 73

    CrossRef

  3. 3
    Haneen Shalabi, Anne Angiolillo, Terry J. Fry, Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia, Frontiers in Pediatrics, 2015, 3,

    CrossRef

  4. 4
    M. P. Tan, A. B. Gerry, J. E. Brewer, L. Melchiori, J. S. Bridgeman, A. D. Bennett, N. J. Pumphrey, B. K. Jakobsen, D. A. Price, K. Ladell, A. K. Sewell, T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells, Clinical & Experimental Immunology, 2015, 180, 2
  5. 5
    John J. Zaunders, Yves Lévy, Nabila Seddiki, Exploiting differential expression of the IL-7 receptor on memory T cells to modulate immune responses, Cytokine & Growth Factor Reviews, 2014, 25, 4, 391

    CrossRef

  6. 6
    R. Ordoñez, L.A. Henríquez-Hernández, M. Federico, A. Valenciano, B. Pinar, M. Lloret, E. Bordón, C. Rodríguez-Gallego, P.C. Lara, Radio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients, Strahlentherapie und Onkologie, 2014, 190, 2, 210

    CrossRef

  7. 7
    Guohong Song, Xiaoli Wang, Jun Jia, Yanhua Yuan, Fengling Wan, Xinna Zhou, Huabing Yang, Jun Ren, Jiezhun Gu, Herbert Kim Lyerly, Elevated level of peripheral CD8+CD28− T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy, Cancer Immunology, Immunotherapy, 2013, 62, 6, 1123

    CrossRef

  8. 8
    Yanyun Zhu, Jie Li, Fangfang Jing, Tiefeng Ji, Xiaoqin Guo, Junlan Yang, Shunchang Jiao, Evaluation of the immune factors in the tumor environment before and after the treatment of cetuximab combined with chemotherapy, World Journal of Surgical Oncology, 2013, 11, 1, 226

    CrossRef

  9. 9
    Stanley R Frankel, Patrick A Baeuerle, Targeting T cells to tumor cells using bispecific antibodies, Current Opinion in Chemical Biology, 2013, 17, 3, 385

    CrossRef

  10. 10
    A. G. Chapuis, G. B. Ragnarsson, H. N. Nguyen, C. N. Chaney, J. S. Pufnock, T. M. Schmitt, N. Duerkopp, I. M. Roberts, G. L. Pogosov, W. Y. Ho, S. Ochsenreither, M. Wolfl, M. Bar, J. P. Radich, C. Yee, P. D. Greenberg, Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients, Science Translational Medicine, 2013, 5, 174, 174ra27

    CrossRef

  11. 11
    Dwain Irvin, Chirag Patil, Keith Black, The Textbook of Nanoneuroscience and Nanoneurosurgery, 2013,

    CrossRef

  12. 12
    M. Peakman, Broadening the translational immunology landscape, Clinical & Experimental Immunology, 2012, 170, 3
  13. 13
    Patrick J Hanley, Catherine M Bollard, Immunotherapy highlights from the 2011 meeting of the American Society of Hematology, Expert Review of Hematology, 2012, 5, 2, 145

    CrossRef